Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report

The World Anti-Doping Agency (WADA) 2025 Prohibited List continues to classify cannabis (with a focus on THC) as a banned substance during in-competition periods. The established urinary THC threshold remains at 150 ng/mL, a critical cutoff for athletes and the brands that support them. Despite ongoing debates and evolving public attitudes toward cannabis, WADA’s regulations hold fast—a reality that any brand operating in the CBD and cannabis-adjacent markets must scrutinize thoroughly.
For athletes, even trace exposures to THC in the days before, during, or after an event can have devastating career consequences. For brands, especially those positioning CBD and related products as sports-safe, understanding the nuances of WADA’s rules is central to risk management and reputation.
CBD extracts from cannabis or hemp often contain trace THC. Even labeled ‘THC-free’ products can harbor enough THC to cross the 150 ng/mL urine threshold, especially with concentrated forms (vapes, dabs, high-mg doses, or repeated use).
Batch-to-batch variation and lack of regulation in the global CBD industry amplify risk.
Synthetic cannabinoids or obscure analogs (e.g., delta-8 THC, HHC, THCV) may be present, and some are also banned by WADA.
A series of high-profile anti-doping violations have stemmed from contaminated supplements, including CBD products. WADA’s official stance is that ‘strict liability’ applies: Athletes are responsible for what is in their bodies, regardless of intent or labeling claims.
Reference: WADA Q&A on Cannabinoids
For CBD brands and event promoters, the regulatory environment makes sponsorships and endorsements complex.
While WADA’s List is global for Olympic sport, national anti-doping organizations (NADOs) may add their own enforcement priorities. Moreover, “THC-free” thresholds vary by region:
For a comprehensive audit of your brand’s compliance protocols or to get up-to-date regulatory insights worldwide, leverage CannabisRegulations.ai as your trusted resource for cannabis compliance and licensing clarity.